{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:13:38Z","timestamp":1791062018494,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The emergence and spread of carbapenem-resistant <jats:italic>Morganella morganii<\/jats:italic> (<jats:italic>M. morganii<\/jats:italic>) pose a serious global challenge. This study aimed to investigate the clinical characteristics, resistance patterns, and molecular mechanisms of carbapenem-resistant <jats:italic>M. morganii<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 170 <jats:italic>M. morganii<\/jats:italic> clinical isolates were collected from the First Affiliated Hospital of Wenzhou Medical University (Wenzhou, China) between January 2016 and December 2017. Carbapenem MICs were determined by antimicrobial susceptibility testing. Carbapenem resistance determinants, including carbapenemase genes (<jats:italic>bla<\/jats:italic><jats:sub>KPC-2<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>VIM<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>IMP<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>NDM<\/jats:sub>, and <jats:italic>bla<\/jats:italic><jats:sub>OXA-48<\/jats:sub>) and extended-spectrum \u03b2-lactamase (ESBL) genes (<jats:italic>bla<\/jats:italic><jats:sub>TEM<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>CTX-M-1<\/jats:sub>, and <jats:italic>bla<\/jats:italic><jats:sub>SHV<\/jats:sub>), were analyzed by polymerase chain reaction (PCR). PCR and sequencing assays were performed to detect penicillin-binding protein (PBP) mutations. Efflux pump activity was also assessed in carbapenem-resistant isolates. Quantitative real-time PCR (qRT-PCR) was used to determine the relative mRNA expression levels of outer membrane porin-encoding gene <jats:italic>ompC<\/jats:italic> and PBP activator-encoding genes <jats:italic>lpoA<\/jats:italic> and <jats:italic>lpoB<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-six imipenem-resistant and 108 imipenem-intermediate <jats:italic>M. morganii<\/jats:italic> isolates were identified, accounting for 15.29% and 63.53% of cases, respectively. No isolates were resistant to meropenem or ertapenem. Among the 26 carbapenem-resistant isolates, the prevalence of ESBL genes <jats:italic>bla<\/jats:italic><jats:sub>TEM<\/jats:sub> and <jats:italic>bla<\/jats:italic><jats:sub>CTX-M-1<\/jats:sub> was 30.77% and 11.54%, respectively, while carbapenemase genes were not detected. Resistant isolates carried more specific PBP mutations than carbapenem-susceptible and carbapenem-intermediate isolates. Efflux pump phenotypes were associated with reduced imipenem susceptibility in 13 carbapenem-resistant isolates. qRT-PCR revealed no significant differences in <jats:italic>ompC<\/jats:italic> expression among the resistant, intermediate, and susceptible groups; however, significant differences were observed in <jats:italic>lpoA<\/jats:italic> and <jats:italic>lpoB<\/jats:italic> expression. Isolates in the imipenem-resistant group carried more PBP mutations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p><jats:italic>M. morganii<\/jats:italic> isolates were commonly non-susceptible to imipenem but remained susceptible to meropenem and ertapenem. Low expression of PBP activator genes (<jats:italic>lpoA<\/jats:italic> and <jats:italic>lpoB<\/jats:italic>), along with the presence of specific PBP mutations, appeared to be the primary mechanisms of resistance. In addition, efflux pump overexpression may contribute to imipenem resistance in <jats:italic>M. morganii<\/jats:italic>.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2025.1672736","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T05:24:53Z","timestamp":1757049893000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics, specific resistance patterns, and molecular mechanisms of carbapenem-resistant Morganella morganii isolates"],"prefix":"10.3389","volume":"15","author":[{"given":"Xiangkuo","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luozhu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changrui","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/jac\/dkv318","article-title":"A new mechanism to render clinical isolates of Escherichia coli non-susceptible to imipenem: substitutions in the PBP2 penicillin-binding domain","volume":"71","author":"Aissa","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/cid\/ciae229","article-title":"The growing threat of NDM-producing escherichia coli with penicillin-binding protein 3 mutations in the United States-is there a potential role for durlobactam","volume":"79","author":"Aitken","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.puhe.2020.01.016","article-title":"Ringing bells: Morganella morganii fights for recognition","volume":"182","author":"Bandy","year":"2020","journal-title":"Public Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1177\/15353702231208407","article-title":"Penicillin-binding protein (PBP) inhibitor development: A 10-year chemical perspective","volume":"248","author":"Bertonha","year":"2023","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1016\/S2666-5247(23)00407-X","article-title":"Spread of carbapenemase-producing Morganella spp from 2013 to 2021: a comparative genomic study","volume":"5","author":"Bonnin","year":"2024","journal-title":"Lancet Microbe"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1179\/1973947812Y.0000000032","article-title":"Carbapenems","volume":"25","author":"Breilh","year":"2013","journal-title":"J. Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0030624","DOI":"10.1128\/msystems.00306-24","article-title":"Tracing the possible evolutionary trends of Morganella morganii: insights from molecular epidemiology and phylogenetic analysis","volume":"9","author":"Chen","year":"2024","journal-title":"mSystems"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02676","article-title":"Transcriptional Modulation of Penicillin-Binding Protein 1b, Outer Membrane Protein P2 and Efflux Pump (AcrAB-TolC) during Heat Stress Is Correlated to Enhanced Bactericidal Action of Imipenem on Non-typeable Haemophilus influenzae","volume":"8","author":"Cherkaoui","year":"2017","journal-title":"Front. Microbiol."},{"key":"B9","article-title":"Performance standard for antimicrobial susceptibility testing","volume-title":"CLSI supplement M100","year":"2025"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1128\/IAI.00012-14","article-title":"Differential requirement for PBP1a and PBP1b in in vivo and in vitro fitness of Vibrio cholerae","volume":"82","author":"Dorr","year":"2014","journal-title":"Infect. Immun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"8197","DOI":"10.1073\/pnas.1400376111","article-title":"Outer-membrane lipoprotein LpoB spans the periplasm to stimulate the peptidoglycan synthase PBP1B","volume":"111","author":"Egan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jmii.2017.08.010","article-title":"Clinical manifestations, risk factors and prognosis of patients with Morganella morganii sepsis","volume":"52","author":"Erlanger","year":"2019","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/cid\/ciae343","article-title":"Chances\/challenges of the role of new beta-lactamase inhibitors against the growing threat of NDM-producing escherichia coli with penicillin-binding protein 3 mutations","volume":"80","author":"Fabrizio","year":"2025","journal-title":"Clin. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1128\/MMBR.66.4.702-738.2002","article-title":"Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent","volume":"66","author":"Goffin","year":"2002","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1073\/pnas.1717925115","article-title":"Conserved mechanism of cell-wall synthase regulation revealed by the identification of a new PBP activator in Pseudomonas aeruginosa","volume":"115","author":"Greene","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01156","article-title":"Detection and genomic characterization of a morganella morganii isolate from China that produces NDM-5","volume":"10","author":"Guo","year":"2019","journal-title":"Front. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"27528","DOI":"10.1021\/acs.jafc.4c07028","article-title":"Production of natural penicillin-binding protein 2 and development of a signal-amplified fluorescence polarization assay for the determination of 28 beta-lactam antibiotics in milk","volume":"72","author":"Hu","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.str.2014.04.017","article-title":"Elongated structure of the outer-membrane activator of peptidoglycan synthesis LpoA: implications for PBP1A stimulation","volume":"22","author":"Jean","year":"2014","journal-title":"Structure"},{"key":"B19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1128\/AAC.48.2.453-459.2004","article-title":"PBP 2a mutations producing very-high-level resistance to beta-lactams","volume":"48","author":"Katayama","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"19245","DOI":"10.1074\/jbc.M114.565879","article-title":"Structural insights into the lipoprotein outer membrane regulator of penicillin-binding protein 1B","volume":"289","author":"King","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00569-22","article-title":"Morganella morganii, an emerging cause of bloodstream infections","volume":"10","author":"Laupland","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/pauz.19960250107","article-title":"Penicillin\u2013binding protein: the target for beta-lactam antibiotics, beta-lactamases and their inhibitors","volume":"25","author":"Lessel","year":"1996","journal-title":"Pharm. Unserer Zeit"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101180","article-title":"Global phylogeography and antibiotic resistance characteristics of Morganella: An epidemiological, spatial, comparative genomic study","volume":"78","author":"Liu","year":"2025","journal-title":"Drug Resist. Update"},{"key":"B24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijid.2016.07.006","article-title":"Morganella morganii, a non-negligent opportunistic pathogen","volume":"50","author":"Liu","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e01221-20","DOI":"10.1128\/AAC.01221-20","article-title":"Cefiderocol Resistance in Acinetobacter baumannii: Roles of beta-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3","volume":"64","author":"Malik","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2025.110585","article-title":"Emergence of carbapenem resistant Escherichia coli, Morganella morganii, Providencia rettgeri harboring bla(NDM) genes in minks from China","volume":"307","author":"Munir","year":"2025","journal-title":"Vet. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.molmed.2012.03.003","article-title":"Carbapenem resistance in Enterobacteriaceae: here is the storm","volume":"18","author":"Nordmann","year":"2012","journal-title":"Trends Mol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2010.11.037","article-title":"Lipoprotein cofactors located in the outer membrane activate bacterial cell wall polymerases","volume":"143","author":"Paradis-Bleau","year":"2010","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2052-2058","DOI":"10.3390\/ani10112052","article-title":"Emergence of third-generation cephalosporin-resistant morganella morganii in a captive breeding dolphin in South Korea","volume":"10","author":"Park","year":"2020","journal-title":"Anim. (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/ki.2014.23","article-title":"White urine due to urinary tract infection","volume":"86","author":"Sakaguchi","year":"2014","journal-title":"Kidney Int."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112312","article-title":"Penicillin binding protein 2a: An overview and a medicinal chemistry perspective","volume":"199","author":"Shalaby","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1128\/AAC.00260-09","article-title":"Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China","volume":"53","author":"Shen","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10096-011-1377-9","article-title":"Identification of bla KPC-2 on different plasmids of three Morganella morganii isolates","volume":"31","author":"Shi","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1099\/jmm.0.001160","article-title":"Highly multidrug-resistant Morganella morganii clinical isolates from Nepal co-producing NDM-type metallo-beta-lactamases and the 16S rRNA methylase ArmA","volume":"69","author":"Shrestha","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107256","article-title":"Resistance to aztreonam-avibactam among clinical isolates of Escherichia coli is primarily mediated by altered penicillin-binding protein 3 and impermeability","volume":"64","author":"Tellapragada","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B37","doi-asserted-by":"publisher","first-page":"pii=30262","DOI":"10.2807\/1560-7917.ES.2016.21.25.30262","article-title":"Active surveillance scheme in three Romanian hospitals reveals a high prevalence and variety of carbapenamase-producing Gram-negative bacteria: a pilot study, December 2014 to May 2015","volume":"21","author":"Timofte","year":"2016","journal-title":"Euro Surveill"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.cell.2010.11.038","article-title":"Regulation of peptidoglycan synthesis by outer-membrane proteins","volume":"143","author":"Typas","year":"2010","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.744291","article-title":"Clinical molecular and genomic epidemiology of morganella morganii in China","volume":"12","author":"Xiang","year":"2021","journal-title":"Front. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02476-24","article-title":"Carbapenem-resistant Morganella morganii carrying bla(KPC-2) or bla(NDM-1) in the clinic: one-decade genomic epidemiology analysis","volume":"13","author":"Yao","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1128\/AAC.04669-14","article-title":"PBP1a\/LpoA but not PBP1b\/LpoB are involved in regulation of the major beta-lactamase gene blaA in Shewanella oneidensis","volume":"59","author":"Yin","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ijmmb.2021.06.005","article-title":"Antimicrobial treatment of Morganella morganii invasive infections: Systematic review","volume":"39","author":"Zaric","year":"2021","journal-title":"Indian J. Med. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106605","article-title":"Clinical characteristics, tolerance mechanisms, and molecular epidemiology of reduced susceptibility to chlorhexidine among Pseudomonas aeruginosa isolated from a teaching hospital in China","volume":"60","author":"Zheng","year":"2022","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1672736\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T05:24:54Z","timestamp":1757049894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1672736\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":43,"alternative-id":["10.3389\/fcimb.2025.1672736"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1672736","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"article-number":"1672736"}}